Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Meridian Bioscience, Inc. (VIVO)

-NasdaqGS
19.71 0.56(2.76%) Jul 31, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 50,134   44,794   48,962   47,108  
Cost of Revenue18,541  16,787  18,088  16,477  
Gross Profit 31,593   28,007   30,874   30,631  
Operating Expenses
Research Development3,186  2,853  2,748  2,711  
Selling General and Administrative12,741  13,528  14,855  12,221  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 15,666   11,626   13,271   15,699  
Income from Continuing Operations
Total Other Income/Expenses Net(22)(216)(215)(148)
Earnings Before Interest And Taxes15,644  11,410  13,056  15,551  
Interest Expense -   -   -   -  
Income Before Tax15,644  11,410  13,056  15,551  
Income Tax Expense5,344  3,984  3,906  5,392  
Minority Interest -   -   -   -  
Net Income From Continuing Ops10,300  7,426  9,150  10,159  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 10,300   7,426   9,150   10,159  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 10,300   7,426   9,150   10,159  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.